Cargando…
Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms
The control of infectious diseases is a major current challenge in intensive aquaculture. Most commercial vaccines are based on live attenuated or inactivated pathogens that are usually combined with adjuvants, oil emulsions being as the most widely used for vaccination in aquaculture. Although effe...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055299/ https://www.ncbi.nlm.nih.gov/pubmed/27716780 http://dx.doi.org/10.1371/journal.pone.0164073 |
_version_ | 1782458744830951424 |
---|---|
author | Torrealba, Débora Seras-Franzoso, Joaquin Mamat, Uwe Wilke, Kathleen Villaverde, Antonio Roher, Nerea Garcia-Fruitós, Elena |
author_facet | Torrealba, Débora Seras-Franzoso, Joaquin Mamat, Uwe Wilke, Kathleen Villaverde, Antonio Roher, Nerea Garcia-Fruitós, Elena |
author_sort | Torrealba, Débora |
collection | PubMed |
description | The control of infectious diseases is a major current challenge in intensive aquaculture. Most commercial vaccines are based on live attenuated or inactivated pathogens that are usually combined with adjuvants, oil emulsions being as the most widely used for vaccination in aquaculture. Although effective, the use of these oil emulsions is plagued with important side effects. Thus, the development of alternative safer and cost-effective immunostimulants and adjuvants is highly desirable. Here we have explored the capacity of inclusion bodies produced in bacteria to immunostimulate and protect fish against bacterial infections. Bacterial inclusion bodies are highly stable, non-toxic protein-based biomaterials produced through fully scalable and low-cost bio-production processes. The present study shows that the composition and structured organization of inclusion body components (protein, lipopolysaccharide, peptidoglycan, DNA and RNA) make these protein biomaterials excellent immunomodulators able to generically protect fish against otherwise lethal bacterial challenges. The results obtained in this work provide evidence that their inherent nature makes bacterial inclusion bodies exceptionally attractive as immunostimulants and this opens the door to the future exploration of this biomaterial as an alternative adjuvant for vaccination purposes in veterinary. |
format | Online Article Text |
id | pubmed-5055299 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-50552992016-10-27 Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms Torrealba, Débora Seras-Franzoso, Joaquin Mamat, Uwe Wilke, Kathleen Villaverde, Antonio Roher, Nerea Garcia-Fruitós, Elena PLoS One Research Article The control of infectious diseases is a major current challenge in intensive aquaculture. Most commercial vaccines are based on live attenuated or inactivated pathogens that are usually combined with adjuvants, oil emulsions being as the most widely used for vaccination in aquaculture. Although effective, the use of these oil emulsions is plagued with important side effects. Thus, the development of alternative safer and cost-effective immunostimulants and adjuvants is highly desirable. Here we have explored the capacity of inclusion bodies produced in bacteria to immunostimulate and protect fish against bacterial infections. Bacterial inclusion bodies are highly stable, non-toxic protein-based biomaterials produced through fully scalable and low-cost bio-production processes. The present study shows that the composition and structured organization of inclusion body components (protein, lipopolysaccharide, peptidoglycan, DNA and RNA) make these protein biomaterials excellent immunomodulators able to generically protect fish against otherwise lethal bacterial challenges. The results obtained in this work provide evidence that their inherent nature makes bacterial inclusion bodies exceptionally attractive as immunostimulants and this opens the door to the future exploration of this biomaterial as an alternative adjuvant for vaccination purposes in veterinary. Public Library of Science 2016-10-07 /pmc/articles/PMC5055299/ /pubmed/27716780 http://dx.doi.org/10.1371/journal.pone.0164073 Text en © 2016 Torrealba et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Torrealba, Débora Seras-Franzoso, Joaquin Mamat, Uwe Wilke, Kathleen Villaverde, Antonio Roher, Nerea Garcia-Fruitós, Elena Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms |
title | Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms |
title_full | Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms |
title_fullStr | Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms |
title_full_unstemmed | Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms |
title_short | Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms |
title_sort | complex particulate biomaterials as immunostimulant-delivery platforms |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055299/ https://www.ncbi.nlm.nih.gov/pubmed/27716780 http://dx.doi.org/10.1371/journal.pone.0164073 |
work_keys_str_mv | AT torrealbadebora complexparticulatebiomaterialsasimmunostimulantdeliveryplatforms AT serasfranzosojoaquin complexparticulatebiomaterialsasimmunostimulantdeliveryplatforms AT mamatuwe complexparticulatebiomaterialsasimmunostimulantdeliveryplatforms AT wilkekathleen complexparticulatebiomaterialsasimmunostimulantdeliveryplatforms AT villaverdeantonio complexparticulatebiomaterialsasimmunostimulantdeliveryplatforms AT rohernerea complexparticulatebiomaterialsasimmunostimulantdeliveryplatforms AT garciafruitoselena complexparticulatebiomaterialsasimmunostimulantdeliveryplatforms |